Human TCR recognizes TEL1 peptide (MLWGYLQYV) in the context of HLA-A2. Soluble TCR expressed with ZIP-Fos/ZIP-Jun strategy (TRAV-TRAC partial-ZIP-Fos, TRBV-TRBC partial-ZIP-Jun) was validated to be able to bind pMHC in published references. The same expression strategy (ZIP-Fos/ZIP-Jun) is used to express this recombinant Human soluble TCR. Please note that the activity is not guaranteed.

Specifications

Host Species
Human

Target
TEL1

Species Reactivity
S. cerevisiae AWRI796

Epitope
MLWGYLQYV

MHC
HLA-A2

Type
Soluble TCR (ZIP-Fos/ZIP-Jun)

Related Disease
Crohn's disease

TCR Expression Strategy
ZIP-Fos/ZIP-Jun strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on ZIP-Fox/ZIP-Jun. The soluble TCR contains variable regions and partial constant regions.

See other products for "TEL1"

CAT

Product Name

Application

Type

MHC-LC1496

PE-A*02:01/TEL1 (MLWGYLQYV) MHC Tetramer

FCM

MHC-LC1497

APC-A*02:01/TEL1 (MLWGYLQYV) MHC Tetramer

FCM

MHC-LC1498

BV421-A*02:01/TEL1 (MLWGYLQYV) MHC Tetramer

FCM

Customer Reviews and Q&As

There are currently no Customer reviews or questions for VS-0622-YF416. Click the button above to contact us or submit your feedback about this product.